NSE · KILITCH
Kilitch Drugs (India) Limited (KILITCH) Share Price
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#1,655
of 5,047 stocks
▲ 1091W▲ 221M
Peak #1,645 · 11 Oct 2026
Kilitch Drugs (India) Limited, a smallcap Healthcare business, remains firmly promoter-controlled, with promoters holding 64%, is growing revenue at a solid clip, and commands a premium earnings multiple.
Market Cap
834.04 Cr
P/E Ratio
26.77
P/B Ratio
3.01
ROE
10.66%
ROCE
13.15%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q2 2026-27 | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 |
|---|---|---|---|---|
| Revenue | 50.22 Cr | 44.88 Cr | 89.60 Cr | 53.81 Cr |
| Net Profit | 1.41 Cr | 1.97 Cr | 14.88 Cr | 4.32 Cr |
| EPS | 0.64 | 0.83 | 4.24 | 2.50 |
| Operating Profit | 5.02 Cr | 4.74 Cr | 21.65 Cr | 6.74 Cr |
Shareholding pattern
Promoter
63.77%
Public
36.23%
PUBLIC BREAKDOWN
FII
0.12%
DII
0.00%
MF (within DII)
0.00%
Individuals
30.82%
Mutual fund holdings
₹0.01
Cr total
2
Schemes
2
Fund Houses
₹0.01 Cr
Total Exposure
Motilal Oswal Mutual Fund₹0.01 Cr (67.3%)
Bandhan Mutual Fund₹0.00 Cr (32.7%)
| Scheme | Fund House | Value (Cr) | % |
|---|
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 24 Mar 2026 | Bonus | Bonus 1:1 |
| 15 Jul 2025 | Rights | Rights 2:23 @ Premium Rs 347/- |
| 19 Sep 2024 | Other | Annual General Meeting |
| 21 Sep 2023 | Other | Annual General Meeting |
| 20 Sep 2022 | Other | Annual General Meeting |
Other Healthcare stocks
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.